{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:22:18Z","timestamp":1789381338732,"version":"build-2803163510"},"reference-count":30,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2005,11,24]],"date-time":"2005-11-24T00:00:00Z","timestamp":1132790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HIV Medicine"],"published-print":{"date-parts":[[2006,1]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>To establish the prevalence and quantify the severity of body fat redistribution and dyslipidaemia in HIV\u2010infected men after long\u2010term highly active antiretroviral therapy (HAART) compared with the background population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>In a cross\u2010sectional study, we included 87 HIV\u2010infected men who had received HAART for at least 6 years and 34 HIV\u2010negative men. Regional body composition was assessed using dual\u2010energy X\u2010ray absorptiometry. Fasting metabolic parameters were obtained. Associations between regional body fat distribution and metabolic parameters were evaluated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>HIV\u2010infected patients and controls did not differ with regard to height and lean body mass. Compared with controls, HIV\u2010infected men had reduced total fat mass (median 12.3 versus 19.2\u2003kg, <jats:italic>P<\/jats:italic>&lt;0.001), limb fat mass (4.3 versus 7.9\u2003kg, <jats:italic>P<\/jats:italic>&lt;0.001), and trunk fat mass (6.7 versus 10.8\u2003kg, <jats:italic>P<\/jats:italic>&lt;0.001) and higher trunk\/limb fat ratio (1.7 versus 1.2, <jats:italic>P<\/jats:italic>&lt;0.001). Also, patients without clinical lipodystrophy had reduced amounts of limb and trunk fat. In HIV\u2010infected men, triglyceride levels were higher (2.0 versus 1.2 mmol\/L, <jats:italic>P<\/jats:italic>&lt;0.001), high\u2010density lipoprotein (HDL)\u2010cholesterol levels were lower (1.2 versus 1.3 mmol\/L, <jats:italic>P<\/jats:italic>&lt;0.05) and insulin levels were higher (40.8 versus 29.9 pmol\/L, <jats:italic>P<\/jats:italic>&lt;0.01) than in controls. All adverse metabolic parameters correlated with increased trunk\/limb fat ratio, and insulin levels correlated positively with trunk fat mass (<jats:italic>P&lt;<\/jats:italic>0.01).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Peripheral as well as central fat loss is a general characteristic of HIV\u2010infected men after long\u2010term HAART. Although lipoatrophy was the dominant morphological presentation, the adverse metabolic parameters were mainly associated with the increased ratio of trunk\/limb fat.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1468-1293.2005.00334.x","type":"journal-article","created":{"date-parts":[[2005,11,24]],"date-time":"2005-11-24T16:57:32Z","timestamp":1132851452000},"page":"38-45","source":"Crossref","is-referenced-by-count":24,"title":["Pronounced lipoatrophy in HIV\u2010infected men receiving HAART for more than 6 years compared with the background population"],"prefix":"10.1111","volume":"7","author":[{"given":"AB","family":"Hansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Lindegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Obel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Gerstoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,11,24]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199807000-00003"},{"key":"e_1_2_6_3_2","first-page":"2093","article-title":"Diagnosis, prediction, and natural course of HIV\u20101 protease\u2010inhibitor\u2010associated lipodystrophy, hyperlipidaemia, and diabetes mellitus","volume":"353","author":"Carr A","year":"1999","journal-title":"a cohort study"},{"key":"e_1_2_6_4_2","first-page":"L18 [Abstract 2","article-title":"Prospective evaluation of regional body composition in antiretroviralnaive subjects randomized to receive zidovudine+lamivudine or didanosine+stavudine combined with nelfinavir, efavirenz or both","volume":"7","author":"Dube M","year":"2002","journal-title":"A5005s, a substudy of ACTG 384"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200305020-00005"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200107270-00008"},{"key":"e_1_2_6_7_2","first-page":"293","article-title":"HIV lipodystrophy","volume":"4","author":"Miller J","year":"2003","journal-title":"prevalence, severity and correlates of risk in Australia"},{"key":"e_1_2_6_8_2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/135965350200700306","article-title":"Evaluation of the risk factors associated with lipodystrophy development in a cohort of HIV\u2010positive patients","volume":"7","author":"Seminari E","year":"2002","journal-title":"Antivir Ther"},{"key":"e_1_2_6_9_2","first-page":"2447","article-title":"Increased risk of lipoatrophy under stavudine in HIV\u20101\u2010infected patients","volume":"16","author":"Joly V","year":"2002","journal-title":"results of a substudy from a comparative trial"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200007070-00002"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1177\/135965350300800614"},{"key":"e_1_2_6_12_2","first-page":"207","article-title":"Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy","volume":"288","author":"Carr A","year":"2002","journal-title":"a randomized trial"},{"key":"e_1_2_6_13_2","first-page":"263","article-title":"Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus\u2010infected patients switched from stavudine to abacavir or zidovudine","volume":"38","author":"McComsey GA","year":"2004","journal-title":"the results of the TARHEEL study"},{"key":"e_1_2_6_14_2","first-page":"191","article-title":"Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral\u2010naive patients","volume":"292","author":"Gallant JE","year":"2004","journal-title":"a 3-year randomized trial"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000143599.64234.15"},{"key":"e_1_2_6_16_2","first-page":"338","article-title":"Demographics of HIV\u20101 infection in Denmark","volume":"37","author":"Lohse N","year":"2005","journal-title":"Results from The Danish HIV Cohort Study"},{"key":"e_1_2_6_17_2","first-page":"726","article-title":"An objective case definition of lipodystrophy in HIV\u2010infected adults","volume":"361","author":"Carr A","year":"2003","journal-title":"a case-control study"},{"key":"e_1_2_6_18_2","first-page":"412","article-title":"Homeostasis model assessment","volume":"28","author":"Matthews DR","year":"1985","journal-title":"insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200312150-00003"},{"key":"e_1_2_6_20_2","unstructured":"GrunfeldC.Basic sciences and metabolic disturbances.XIV. International AIDS Conference. Barcelona Spain July 2002 [Abstract TuOr158]."},{"key":"e_1_2_6_21_2","first-page":"1029","article-title":"Reversibility of lipoatrophy in HIV\u2010infected patients 2 years after switching from a thymidine analogue to abacavir","volume":"18","author":"Martin A","year":"2004","journal-title":"the MITOX Extension Study"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365540410019273"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)06102-4"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1151"},{"key":"e_1_2_6_25_2","first-page":"205","article-title":"Asymptomatic hyperlactataemia","volume":"9","author":"McComsey GA","year":"2004","journal-title":"predictive value, natural history and correlates"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00056.2003"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1053\/meta.2001.21693"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-1293.2002.00125.x"},{"key":"e_1_2_6_29_2","first-page":"37","article-title":"Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy","volume":"14","author":"Saint\u2010Marc T","year":"2000","journal-title":"preliminary results of the LIPOCO study"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/00126334-200012010-00004"},{"key":"e_1_2_6_31_2","unstructured":"FrankI SteppanCM KimRJ BrowerR TownsendRR.Altered adiponectin and leptin regulation but not resistin are associated with insulin resistance and body fat redistribution in HIV patients on antiviral therapy.XV. International AIDS Conference. Bangkok Thailand July 2004 [Abstract WePpB2062]."}],"container-title":["HIV Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1293.2005.00334.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1293.2005.00334.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T16:04:49Z","timestamp":1696867489000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1293.2005.00334.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,24]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["10.1111\/j.1468-1293.2005.00334.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1293.2005.00334.x","archive":["Portico"],"relation":{},"ISSN":["1464-2662","1468-1293"],"issn-type":[{"value":"1464-2662","type":"print"},{"value":"1468-1293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,11,24]]}}}